Company recommends interim dividend of Rs. 3 per share
20 October 2016: India’s leading animal healthcare company, Hester Biosciences Limited has reported the following Q2 FY17 results:
Financial Highlights
FY17 - FY16
Q2 Comparison
FY17 - FY16
H1 Comparison
FY17
FY16
Growth
FY17
FY16
Growth
Net Sales
INR Cr
29.63
24.01
23%
59.76
48.53
23%
Net Profit
INR Cr
↧